PI
BMRN icon

PEAK6 Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

PEAK6 Investments’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$141K Hold
2,000
– – ﹤0.01% 2901
2024
Q2 		$165K Hold
2,000
– – ﹤0.01% 2843
2024
Q1 		$175K Hold
2,000
– – ﹤0.01% 3138
2023
Q4 		$193K Buy
+2,000
New +$177K ﹤0.01% 3270
2023
Q2 		– Sell
-31,500
Closed -$3.06M – 3950
2023
Q1 		$3.06M Buy
+31,500
New +$3.27M 0.01% 994
2022
Q1 		– Sell
-7,500
Closed -$663K – 5225
2021
Q4 		$663K Sell
7,500
-132,200
-95% -$10.9M ﹤0.01% 2960
2021
Q3 		$10.8M Sell
139,700
-8,300
-6% -$655K 0.02% 663
2021
Q2 		$12.3M Sell
148,000
-20,800
-12% -$1.65M 0.03% 579
2021
Q1 		$12.7M Buy
168,800
+158,800
+1,588% +$13M 0.03% 521
2020
Q4 		$877K Sell
10,000
-36,600
-79% -$2.9M ﹤0.01% 2602
2020
Q3 		$3.54M Buy
46,600
+41,600
+832% +$4.21M 0.01% 1200
2020
Q2 		$617K Hold
5,000
– – ﹤0.01% 2495
2020
Q1 		$422K Sell
5,000
-36,300
-88% -$3.13M ﹤0.01% 2217
2019
Q4 		$3.49M Sell
41,300
-29,100
-41% -$2.2M 0.02% 783
2019
Q3 		$4.75M Sell
70,400
-22,400
-24% -$1.73M 0.03% 706
2019
Q2 		$7.95M Buy
92,800
+18,100
+24% +$1.55M 0.05% 458
2019
Q1 		$6.64M Sell
74,700
-49,700
-40% -$4.61M 0.04% 554
2018
Q4 		$10.6M Sell
124,400
-148,100
-54% -$14.1M 0.07% 322
2018
Q3 		$26.4M Buy
+272,500
New +$27.2M 0.12% 166

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

PEAK6 Investments's BMRN Position: Q3 2024 in Review

PEAK6 Investments reduced its BioMarin Pharmaceuticals (BMRN) stake by 49% in Q3 2024, selling an estimated $485K and leaving 6,047 shares worth $425K. The position accounts for ﹤0.01% of the portfolio, ranked #2410.

PEAK6 Investments first reported a position in BMRN in Q3 2018 and has held it in 17 quarters since. The position peaked at $6M in Q3 2018. 553 funds tracked by Wall St. Rank hold BMRN as of Q3 2024.

  • PEAK6 Investments held 6,047 shares of BioMarin Pharmaceuticals worth $425K as of Q3 2024.
  • PEAK6 Investments sold 5,800 BioMarin Pharmaceuticals shares in Q3 2024, an estimated $485K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2410 holding.
  • PEAK6 Investments first reported a position in BioMarin Pharmaceuticals in Q3 2018 and has held it in 17 quarters since.
  • PEAK6 Investments's BioMarin Pharmaceuticals position peaked at $6M in Q3 2018.
  • 553 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.